Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Silexion Therapeutics (NASDAQ:SLXN) through any online brokerage.
Other companies in Silexion Therapeutics’s space includes: Alzamend Neuro (NASDAQ:ALZN), Entero Therapeutics (NASDAQ:ENTO), Acurx Pharmaceuticals (NASDAQ:ACXP), Imunon (NASDAQ:IMNN) and Cellectar Biosciences (NASDAQ:CLRB).
Silexion Therapeutics has a consensus price target of $5.00.
The stock price for Silexion Therapeutics (NASDAQ: SLXN) is $2.78 last updated November 10, 2025 at 9:32 AM EST.
There are no upcoming dividends for Silexion Therapeutics.
Silexion Therapeutics’s Q3 earnings are confirmed for Friday, November 21, 2025.
There is no upcoming split for Silexion Therapeutics.
Silexion Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.